Role of Epigallocatechin Gallate on In Vitro Model of Methylglyoxal-induced Amyloidogenesis

Main Article Content

Dr. Altug Kucukgul

Abstract

Introduction: The study aimed to investigate the potential effects of epigallocatechin gallate (EG) on the reflux of methylglyoxal (MG)-induced amyloidogenesis in human glioblastoma (U87) cells. Materials and Methods: The effective concentrations of MG and EG were investigated via Trypan blue test. Glyoxalase-1 (GLO-1), β-amyloid precursor protein (βAPP), and Caspase 3 (Cas 3) expression levels were determined by quantitative real-time polymerase chain reaction and intracellular glutathione (GSH) contents of cells were measured. Results: MG at 250 μM reduced viable cells by 33.4% as compared to control group. However, 5 μM EG pre-treatment before MG prevented 22.4% of the cell loss caused by MG (P ≤ 0.05). MG stimulated βAPP and Caspase 3 levels by 4.13- and 3.46-fold; however, EG pre-treatment inhibited these increases by 1.76 and 3.09, respectively. In addition, EG pre-treatment increased GLO-1 levels by 3.71-fold and GSH levels by 2.30-fold according to MG group. Conclusion: EG demonstrated protective effect against cell death on U87 cells by suppressing amyloidogenic factors and apoptotic stimuli induced by MG.

Downloads

Download data is not yet available.

Article Details

How to Cite
Kucukgul, D. A. (2016). Role of Epigallocatechin Gallate on In Vitro Model of Methylglyoxal-induced Amyloidogenesis. Asian Journal of Pharmaceutics (AJP), 10(03). https://doi.org/10.22377/ajp.v10i03.782
Section
ORIGINAL ARTICLES